ARTICLE | Company News
Peregrine to reaquire Oncolym rights
June 8, 2001 7:00 AM UTC
PPHM will reacquire worldwide marketing rights from Schering (SHR) for Oncolym, a radiolabeled murine Lym-1 monoclonal antibody in Phase I/II testing to treat intermediate and high grade non-Hodgkin's...